Prostate cancer Board decisions

The Board has granted entitlement to a TDIU and basic eligibility for DEA benefits from February 22, 2021 due to the Veteran's service-connected disabilities.

The Veteran's claim for service connection for coronary artery disease, prostate cancer in remission status post radical prostatectomy, diabetes mellitus type II, left lower extremity femoral nerve diabetic neuropathy, left lower extremity sciatic nerve diabetic neuropathy, right lower extremity femoral nerve diabetic neuropathy, and right lower extremity sciatic nerve diabetic neuropathy has been granted with effective dates of July 15, 2019, February 6, 2019, and March 29, 2019 respectively. These conditions are presumed to be related to herbicide exposure at U-Tapao Royal Thai Air Force Base (RTAFB) in Thailand during the Vietnam era.,The Veteran's claim for service connection for prostate cancer was initially denied in June 2002 and became final. The Veteran filed a new Intent to File on February 6, 2019, which led to his claims being reopened and granted with an effective date of February 6, 2019.

The Veteran's prostate and bladder cancers were granted a 100% rating effective October 19, 2022. The earlier claim for increased rating is granted.

The Veteran is granted a 100 percent initial evaluation for prostate cancer, effective May 9, 2022. The rating will continue for the six months following the completion of treatment in July 2022.

The Veteran's appeal is remanded due to the need for an addendum VA medical opinion regarding his prostate cancer and subsequent treatment, including erectile dysfunction.

The Board has denied the Veteran's claims for service connection for chronic prostate problems and erectile dysfunction, finding that there is no credible evidence linking these conditions to his military service.

The Veteran's appeal to reduce the evaluation of his service-connected prostate cancer from 100% to zero percent is dismissed because the August 2023 rating decision was not a final decision and did not result in any reduction in compensation payments.

The Board has decided to remand the case due to a lack of an etiological opinion regarding whether the Veteran's prostate cancer is related to his active service, specifically his exposure to asbestos. The VA examiner must provide such an opinion.

The Board has vacated the denial of TDIU due to inaccurate evidence, and since May 1, 2015, the Veteran's service-connected disabilities have rendered him unable to secure or follow a substantially gainful occupation.

The Board has granted service connection for ischemic heart disease and prostate cancer, finding that the Veteran was exposed to herbicide agents during his service at Clark Air Force Base in the Philippines.

The Board has dismissed the appeals for service connection for various conditions as they are related to a deceased appellant.

The Board has remanded the claims of service connection for COPD, prostate cancer, and diabetes mellitus type II due to insufficient evidence regarding their etiology. The Veteran's exposure to herbicides is also unclear.

The Board has determined that the Veteran's prostate cancer is related to his active-duty service, including exposure to herbicides. The evidence is at least in equipoise as to whether the Veteran's prostate cancer was caused by his time at Ellsworth Air Force Base where he worked with herbicides.

The Veteran's appeal to reopen the claim of service connection for a left ankle disability is granted. The Board has determined that additional development is needed for the proper adjudication of this and other claims.

The Veteran's service-connected prostate cancer and skin cancer were denied as they are not considered to be related to his active duty service.

The Board has remanded the case due to insufficient medical opinions regarding the Veteran's prostate cancer and its relationship to service, particularly asbestos exposure.

Service connection is granted for diabetes mellitus type 2, bilateral lower extremity diabetic peripheral neuropathy, prostate cancer, and hypertension due to herbicide exposure. The issues of service connection for myositis (muscular myopathy), erectile dysfunction, and hypertension on a basis other than as pursuant to the PACT Act are remanded.

The Board has determined that the reduction in the disability rating for residuals of prostate cancer from 100 to 60 percent effective December 1, 2018 was proper.

The Veteran's TDIU claim is dismissed as his service-connected residuals of prostate cancer have been rated at 100% throughout the appeal period, rendering the issue moot.

The Veteran's claim for service connection for prostate cancer due to exposure at Camp Lejeune was denied again because the evidence did not relate to an unestablished fact necessary to substantiate the claim.